| Exchange: |
NasdaqNM |
| Last Open: |
1.95 |
| Day Range: |
1.86 - 1.95 |
| Last Close: |
1.93 |
| Change: |
-0.02 (N/A) |
| Volume: |
185,581 |
| Avg Vol (3m): |
299,006 |
| 52wk Range: |
1.50 - 5.90 |
| Market Cap: |
81,800,000 |
| EBITDA: |
N/A |
| Revenue: |
18,100,000 |
Address:
Nabi Biopharmaceuticals
12276 Wilkins Avenue
Rockville, MD 20852
United States
Web Site:
|
(NABI) DIVIDEND RATINGS:
| Overall Rating: |
|
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. Rating last changed:
Never |
|
| Dividend Yield: |
|
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
|
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Div. Increases: |
|
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating.
|
|
HEADLINES FOR (NABI):
OTHER BIOTECHNOLOGY COMPANIES:
Amgen Inc. (AMGN)
Celgene Corporation (CELG)
Gilead Sciences Inc. (GILD)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
SEE FULL LIST
|
